venBio Select Advisor as of June 30, 2018
Portfolio Holdings for venBio Select Advisor
venBio Select Advisor holds 42 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Immunomedics | 16.1 | $419M | 18M | 23.67 | |
| Mirati Therapeutics | 9.1 | $237M | 4.8M | 49.30 | |
| BioMarin Pharmaceutical (BMRN) | 5.9 | $153M | 1.6M | 94.20 | |
| Amicus Therapeutics (FOLD) | 5.6 | $146M | 9.4M | 15.62 | |
| Ascendis Pharma A S (ASND) | 5.3 | $137M | 2.1M | 66.52 | |
| Madrigal Pharmaceuticals (MDGL) | 5.3 | $137M | 490k | 279.69 | |
| Sarepta Therapeutics (SRPT) | 4.9 | $127M | 959k | 132.18 | |
| Iovance Biotherapeutics (IOVA) | 4.0 | $105M | 8.2M | 12.80 | |
| Horizon Pharma | 3.6 | $93M | 5.6M | 16.56 | |
| Endocyte | 3.0 | $79M | 5.7M | 13.80 | |
| Ptc Therapeutics I (PTCT) | 3.0 | $77M | 2.3M | 33.73 | |
| Spectrum Pharmaceuticals | 2.8 | $72M | 3.4M | 20.96 | |
| Alnylam Pharmaceuticals (ALNY) | 2.7 | $69M | 700k | 98.49 | |
| Zogenix | 2.6 | $66M | 1.5M | 44.20 | |
| Tg Therapeutics (TGTX) | 2.5 | $65M | 5.0M | 13.15 | |
| Argenx Se (ARGX) | 2.5 | $65M | 782k | 82.86 | |
| Puma Biotechnology (PBYI) | 2.4 | $61M | 1.0M | 59.15 | |
| Vanda Pharmaceuticals (VNDA) | 2.0 | $53M | 2.8M | 19.05 | |
| Clovis Oncology | 2.0 | $52M | 1.1M | 45.47 | |
| Pacira Pharmaceuticals (PCRX) | 1.8 | $47M | 1.5M | 32.05 | |
| Viking Therapeutics (VKTX) | 1.6 | $42M | 4.5M | 9.49 | |
| Assembly Biosciences | 1.4 | $38M | 963k | 39.21 | |
| Medicines Company | 1.4 | $35M | 962k | 36.70 | |
| Tricida | 1.3 | $33M | 1.1M | 29.90 | |
| Global Blood Therapeutics In | 1.2 | $32M | 701k | 45.20 | |
| Teligent | 0.7 | $18M | 5.3M | 3.46 | |
| Cymabay Therapeutics | 0.7 | $17M | 1.3M | 13.42 | |
| Dermira | 0.7 | $17M | 1.8M | 9.20 | |
| BioDelivery Sciences International | 0.6 | $16M | 5.4M | 2.95 | |
| Catalyst Pharmaceutical Partners (CPRX) | 0.5 | $14M | 4.5M | 3.12 | |
| Sesen Bio | 0.5 | $13M | 6.8M | 1.95 | |
| Intec Pharma | 0.4 | $11M | 2.6M | 4.40 | |
| Xenon Pharmaceuticals (XENE) | 0.4 | $11M | 1.2M | 9.20 | |
| Fennec Pharmaceuticals (FENC) | 0.4 | $11M | 1.0M | 10.46 | |
| Alimera Sciences | 0.2 | $6.1M | 6.2M | 0.98 | |
| Arrowhead Pharmaceuticals (ARWR) | 0.2 | $6.1M | 450k | 13.60 | |
| Oncosec Med | 0.2 | $5.5M | 4.0M | 1.38 | |
| SPDR S&P Biotech (XBI) | 0.2 | $4.4M | 1.8M | 2.50 | |
| Avrobio Ord (AVRO) | 0.1 | $2.9M | 100k | 28.56 | |
| Pernix Therapeutics Hldgs In dbcv 4.250% 4/0 | 0.1 | $2.6M | 6.0M | 0.44 | |
| Oncobiologics | 0.0 | $581k | 684k | 0.85 | |
| Oncobiologics Inc *w exp 02/18/201 | 0.0 | $12k | 233k | 0.05 |
